• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Overview of the PIONEER Clinical Trial Program for Oral Semaglutide

Video

Results from the PIONEER clinical trials program indicate that the first oral glucagon-like peptide-1 receptor agonist (GLP-1RA), oral semaglutide, provides effective glycemic control across a range of different patient populations.

Click PLAY to watch the video abstract.


Click here to watch the full supplement infographic.


Click here to read full article to this video abstract.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.